Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Outside the Lab

Outside the Lab Public health

Change is Here, But Are We Ready For it?

| Giorgio Stanta

Patient-centric healthcare can only be fully achieved if we change the current organizational methods

Outside the Lab Public health

Accessing Big Pharma's Conscience

| Jayasree K. Iyer

Jayasree K. Iyer, Executive Director of Access to Medicine Foundation, the Netherlands

Outside the Lab Professional development

Speed Versus Safety for Cell Therapy

| Karen Nichols and Jacques Galipeau

We want faster translation of cell therapies, but is it worth sacrificing public trust?

Outside the Lab Drug discovery

Taking Cues from the City of Notions

| Chas Bountra

Boston leads the drug discovery field, and the UK could soon follow suit

Outside the Lab Immunology

Cold War

| James Strachan

A vaccine against the common cold has long eluded us, but now researchers are on its track

Outside the Lab Cancer

A Personnel Story

| Rasha Kelej

The human element is key to tackle rising cancer rates in Africa

Outside the Lab Professional development

Diversity, Equity, and Problem-solving

| Kimberly Tanner

Diversity and equity in the biosciences are about more than just "being nice"

Outside the Lab Clinical trials

See-Through Science at GSK

| Murray Stewart

Opening up our clinical trial results takes investment, but it's the right thing to do

Outside the Lab Biomedical engineering

The Organ Grower

| Charlotte Barker

Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine

Outside the Lab Clinical trials

The March Towards Trial Transparency

| James Cockerill

Many clinical trial results are never reported, but AllTrials hopes to change that

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register